OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
Teresa Rubio‐Tomás
Molecular Biology Reports (2021) Vol. 48, Iss. 11, pp. 7499-7508
Closed Access | Times Cited: 8
Teresa Rubio‐Tomás
Molecular Biology Reports (2021) Vol. 48, Iss. 11, pp. 7499-7508
Closed Access | Times Cited: 8
Showing 8 citing articles:
The Olive Oil Phenolic S-(-)-Oleocanthal Suppresses Colorectal Cancer Progression and Recurrence by Modulating SMYD2-EZH2 and c-MET Activation
M. Tarun, Heba E. Elsayed, Hassan Y. Ebrahim, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 397-397
Open Access
M. Tarun, Heba E. Elsayed, Hassan Y. Ebrahim, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 397-397
Open Access
Integrated computational and biosensor-based strategies for the discovery of allosteric SMYD3 ligands using diperodon as a starting point
Edward A. Fitzgerald, Moira Rachman, Daniela Cederfelt, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118134-118134
Open Access
Edward A. Fitzgerald, Moira Rachman, Daniela Cederfelt, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118134-118134
Open Access
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy
Lihua Mo, Min Deng, Ragini Adhav, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Lihua Mo, Min Deng, Ragini Adhav, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Xin‐Yu Du, Fengchen Shen, Chao Yu, et al.
The FASEB Journal (2025) Vol. 39, Iss. 9
Closed Access
Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
Zongcheng Yang, Fen Liu, Li Zongkai, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Zongcheng Yang, Fen Liu, Li Zongkai, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2
Abu Bakar Siddique, Hassan Y. Ebrahim, Afsana Tajmim, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3542-3542
Open Access | Times Cited: 14
Abu Bakar Siddique, Hassan Y. Ebrahim, Afsana Tajmim, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3542-3542
Open Access | Times Cited: 14
Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
Zhen Xu, Yan Liu, Zhi Pan, et al.
PubMed (2024) Vol. 39, Iss. 2, pp. 263-277
Closed Access | Times Cited: 2
Zhen Xu, Yan Liu, Zhi Pan, et al.
PubMed (2024) Vol. 39, Iss. 2, pp. 263-277
Closed Access | Times Cited: 2
Protein Lysine Methyltransferase SMYD2: A Promising Small Molecule Target for Cancer Therapy
Quan Zheng, Wen Zhang, Guo-Wu Rao
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10119-10132
Closed Access | Times Cited: 5
Quan Zheng, Wen Zhang, Guo-Wu Rao
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10119-10132
Closed Access | Times Cited: 5
